WALTERS GROUP purchased 91.6% of their position (6.46M shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $7.75M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/8/2026ACC: 0001213900-26-002567
10% Owner
Since Dec 2025
+6.46M
Net shares
Net buyer
$7.75M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.46M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.46M
Price / share
$1.20
Trade value
$7.75M
% of position
91.6%
12/31/2025
7.05M→13.51M
Total
Net shares
+6.46M
Net value
$7.75M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | P · Purchase | +6.46M | $1.20 | $7.75M | 91.6% | 7.05M | 13.51M |
| Total | +6.46M | $7.75M | ||||||
Derivative Transactions0
No derivative transactions reported